A GLP-1 in pill form from Eli Lilly shows promising results for weight loss and Type 2 diabetes treatment in a trial. FDA approval is expected in 2026.

The Eli Lilly and Company-Bond has a maturity date of 2/12/2055 and offers a coupon of 5.5000%. The payment of the coupon will take place 2,0 times per biannual on the 12.08.. At the current price ...